nodes	percent_of_prediction	percent_of_DWPC	metapath
Flunitrazepam—CYP2A6—Fluorouracil—head and neck cancer	0.244	0.485	CbGbCtD
Flunitrazepam—CYP1A2—Fluorouracil—head and neck cancer	0.0932	0.185	CbGbCtD
Flunitrazepam—CYP2C9—Fluorouracil—head and neck cancer	0.0839	0.167	CbGbCtD
Flunitrazepam—CYP3A4—Vinblastine—head and neck cancer	0.0452	0.0898	CbGbCtD
Flunitrazepam—CYP3A4—Docetaxel—head and neck cancer	0.0373	0.074	CbGbCtD
Flunitrazepam—Unsteadiness—Fluorouracil—head and neck cancer	0.0276	0.138	CcSEcCtD
Flunitrazepam—Emotional distress—Hydroxyurea—head and neck cancer	0.0181	0.0903	CcSEcCtD
Flunitrazepam—Emotional distress—Fluorouracil—head and neck cancer	0.013	0.065	CcSEcCtD
Flunitrazepam—Slurred speech—Fluorouracil—head and neck cancer	0.0124	0.0618	CcSEcCtD
Flunitrazepam—Balance disorder—Fluorouracil—head and neck cancer	0.0101	0.0506	CcSEcCtD
Flunitrazepam—Clonazepam—NAT2—head and neck cancer	0.00793	1	CrCbGaD
Flunitrazepam—Disorientation—Hydroxyurea—head and neck cancer	0.00625	0.0312	CcSEcCtD
Flunitrazepam—Dysarthria—Fluorouracil—head and neck cancer	0.00586	0.0292	CcSEcCtD
Flunitrazepam—Disorientation—Fluorouracil—head and neck cancer	0.0045	0.0224	CcSEcCtD
Flunitrazepam—Drowsiness—Hydroxyurea—head and neck cancer	0.00431	0.0215	CcSEcCtD
Flunitrazepam—Amnesia—Fluorouracil—head and neck cancer	0.00428	0.0214	CcSEcCtD
Flunitrazepam—Hallucination—Hydroxyurea—head and neck cancer	0.00385	0.0192	CcSEcCtD
Flunitrazepam—Irritability—Fluorouracil—head and neck cancer	0.00384	0.0191	CcSEcCtD
Flunitrazepam—Ataxia—Fluorouracil—head and neck cancer	0.00379	0.0189	CcSEcCtD
Flunitrazepam—Muscular weakness—Fluorouracil—head and neck cancer	0.00355	0.0177	CcSEcCtD
Flunitrazepam—Ill-defined disorder—Vinblastine—head and neck cancer	0.00343	0.0171	CcSEcCtD
Flunitrazepam—Malaise—Vinblastine—head and neck cancer	0.00333	0.0166	CcSEcCtD
Flunitrazepam—Ill-defined disorder—Hydroxyurea—head and neck cancer	0.00312	0.0156	CcSEcCtD
Flunitrazepam—Discomfort—Vinblastine—head and neck cancer	0.00311	0.0155	CcSEcCtD
Flunitrazepam—Malaise—Hydroxyurea—head and neck cancer	0.00304	0.0151	CcSEcCtD
Flunitrazepam—Discomfort—Hydroxyurea—head and neck cancer	0.00283	0.0141	CcSEcCtD
Flunitrazepam—Ataxia—Docetaxel—head and neck cancer	0.00273	0.0136	CcSEcCtD
Flunitrazepam—Orthostatic hypotension—Docetaxel—head and neck cancer	0.00265	0.0132	CcSEcCtD
Flunitrazepam—Feeling abnormal—Vinblastine—head and neck cancer	0.00248	0.0124	CcSEcCtD
Flunitrazepam—Somnolence—Hydroxyurea—head and neck cancer	0.00244	0.0122	CcSEcCtD
Flunitrazepam—Fatigue—Hydroxyurea—head and neck cancer	0.00237	0.0118	CcSEcCtD
Flunitrazepam—Feeling abnormal—Hydroxyurea—head and neck cancer	0.00227	0.0113	CcSEcCtD
Flunitrazepam—Asthenia—Vinblastine—head and neck cancer	0.00216	0.0108	CcSEcCtD
Flunitrazepam—Discomfort—Fluorouracil—head and neck cancer	0.00204	0.0102	CcSEcCtD
Flunitrazepam—Confusional state—Fluorouracil—head and neck cancer	0.00199	0.00994	CcSEcCtD
Flunitrazepam—Dizziness—Vinblastine—head and neck cancer	0.00199	0.00993	CcSEcCtD
Flunitrazepam—Asthenia—Hydroxyurea—head and neck cancer	0.00197	0.00983	CcSEcCtD
Flunitrazepam—Tachycardia—Fluorouracil—head and neck cancer	0.00193	0.00962	CcSEcCtD
Flunitrazepam—Headache—Vinblastine—head and neck cancer	0.00189	0.00941	CcSEcCtD
Flunitrazepam—Hypotension—Fluorouracil—head and neck cancer	0.00185	0.00921	CcSEcCtD
Flunitrazepam—Dizziness—Hydroxyurea—head and neck cancer	0.00182	0.00906	CcSEcCtD
Flunitrazepam—Somnolence—Fluorouracil—head and neck cancer	0.00176	0.00877	CcSEcCtD
Flunitrazepam—Rash—Hydroxyurea—head and neck cancer	0.00173	0.00864	CcSEcCtD
Flunitrazepam—Dermatitis—Hydroxyurea—head and neck cancer	0.00173	0.00863	CcSEcCtD
Flunitrazepam—Headache—Hydroxyurea—head and neck cancer	0.00172	0.00858	CcSEcCtD
Flunitrazepam—Feeling abnormal—Fluorouracil—head and neck cancer	0.00163	0.00813	CcSEcCtD
Flunitrazepam—Dry mouth—Docetaxel—head and neck cancer	0.00146	0.00726	CcSEcCtD
Flunitrazepam—Confusional state—Docetaxel—head and neck cancer	0.00144	0.00718	CcSEcCtD
Flunitrazepam—Tachycardia—Docetaxel—head and neck cancer	0.00139	0.00695	CcSEcCtD
Flunitrazepam—Hypotension—Docetaxel—head and neck cancer	0.00133	0.00665	CcSEcCtD
Flunitrazepam—Dizziness—Fluorouracil—head and neck cancer	0.00131	0.00652	CcSEcCtD
Flunitrazepam—Somnolence—Docetaxel—head and neck cancer	0.00127	0.00633	CcSEcCtD
Flunitrazepam—Rash—Fluorouracil—head and neck cancer	0.00125	0.00622	CcSEcCtD
Flunitrazepam—Dermatitis—Fluorouracil—head and neck cancer	0.00125	0.00621	CcSEcCtD
Flunitrazepam—Headache—Fluorouracil—head and neck cancer	0.00124	0.00618	CcSEcCtD
Flunitrazepam—Fatigue—Docetaxel—head and neck cancer	0.00123	0.00614	CcSEcCtD
Flunitrazepam—Feeling abnormal—Docetaxel—head and neck cancer	0.00118	0.00587	CcSEcCtD
Flunitrazepam—Asthenia—Docetaxel—head and neck cancer	0.00102	0.00511	CcSEcCtD
Flunitrazepam—Dizziness—Docetaxel—head and neck cancer	0.000944	0.00471	CcSEcCtD
Flunitrazepam—Rash—Docetaxel—head and neck cancer	0.0009	0.00449	CcSEcCtD
Flunitrazepam—Dermatitis—Docetaxel—head and neck cancer	0.0009	0.00448	CcSEcCtD
Flunitrazepam—Headache—Docetaxel—head and neck cancer	0.000895	0.00446	CcSEcCtD
Flunitrazepam—CYP2C9—Arachidonic acid metabolism—CYP1A1—head and neck cancer	0.000718	0.00249	CbGpPWpGaD
Flunitrazepam—CYP2E1—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.000715	0.00248	CbGpPWpGaD
Flunitrazepam—GABRA5—Transmembrane transport of small molecules—ATP7B—head and neck cancer	0.000683	0.00238	CbGpPWpGaD
Flunitrazepam—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.00068	0.00236	CbGpPWpGaD
Flunitrazepam—UGT2B7—Metabolism—UROD—head and neck cancer	0.000675	0.00235	CbGpPWpGaD
Flunitrazepam—CYP2C19—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.000671	0.00233	CbGpPWpGaD
Flunitrazepam—GABRA3—Transmembrane transport of small molecules—ATP7B—head and neck cancer	0.000671	0.00233	CbGpPWpGaD
Flunitrazepam—GABRA2—Transmembrane transport of small molecules—ATP7B—head and neck cancer	0.00066	0.00229	CbGpPWpGaD
Flunitrazepam—UGT1A1—Biological oxidations—GSTM1—head and neck cancer	0.000658	0.00229	CbGpPWpGaD
Flunitrazepam—CYP1A2—Tryptophan metabolism—CYP1A1—head and neck cancer	0.000656	0.00228	CbGpPWpGaD
Flunitrazepam—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CYP1A1—head and neck cancer	0.000656	0.00228	CbGpPWpGaD
Flunitrazepam—CYP1A2—Aryl Hydrocarbon Receptor—CYP1A1—head and neck cancer	0.000656	0.00228	CbGpPWpGaD
Flunitrazepam—UGT1A1—Metapathway biotransformation—GSTM1—head and neck cancer	0.000648	0.00225	CbGpPWpGaD
Flunitrazepam—CYP2A6—Fluoropyrimidine Activity—TP53—head and neck cancer	0.000637	0.00221	CbGpPWpGaD
Flunitrazepam—CYP2C19—Biological oxidations—NAT2—head and neck cancer	0.000626	0.00217	CbGpPWpGaD
Flunitrazepam—UGT1A1—Biological oxidations—CYP1A1—head and neck cancer	0.000623	0.00217	CbGpPWpGaD
Flunitrazepam—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.00062	0.00216	CbGpPWpGaD
Flunitrazepam—CYP1A2—Arachidonic acid metabolism—GPX1—head and neck cancer	0.00062	0.00215	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metapathway biotransformation—NAT2—head and neck cancer	0.000617	0.00214	CbGpPWpGaD
Flunitrazepam—UGT1A1—Metapathway biotransformation—CYP1A1—head and neck cancer	0.000615	0.00214	CbGpPWpGaD
Flunitrazepam—CYP1A2—Arachidonic acid metabolism—CYP1A1—head and neck cancer	0.000613	0.00213	CbGpPWpGaD
Flunitrazepam—CYP2C9—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.000612	0.00213	CbGpPWpGaD
Flunitrazepam—CYP2A6—NRF2 pathway—GSTM1—head and neck cancer	0.000578	0.00201	CbGpPWpGaD
Flunitrazepam—CYP2C9—Biological oxidations—NAT2—head and neck cancer	0.000571	0.00198	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metapathway biotransformation—NAT2—head and neck cancer	0.000563	0.00196	CbGpPWpGaD
Flunitrazepam—GABRA1—Transmembrane transport of small molecules—ATP7B—head and neck cancer	0.000562	0.00195	CbGpPWpGaD
Flunitrazepam—CYP2C19—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.000552	0.00192	CbGpPWpGaD
Flunitrazepam—UGT1A1—Metabolism—UROD—head and neck cancer	0.000548	0.00191	CbGpPWpGaD
Flunitrazepam—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.00053	0.00184	CbGpPWpGaD
Flunitrazepam—CYP1A2—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.000523	0.00182	CbGpPWpGaD
Flunitrazepam—CYP2A6—Biological oxidations—GSTM1—head and neck cancer	0.000507	0.00176	CbGpPWpGaD
Flunitrazepam—CYP3A4—Tryptophan metabolism—CYP1A1—head and neck cancer	0.000506	0.00176	CbGpPWpGaD
Flunitrazepam—CYP2C9—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.000503	0.00175	CbGpPWpGaD
Flunitrazepam—CYP1A2—Biological oxidations—NAT2—head and neck cancer	0.000488	0.00169	CbGpPWpGaD
Flunitrazepam—CYP2E1—Vitamin A and Carotenoid Metabolism—MAPK1—head and neck cancer	0.000485	0.00169	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metapathway biotransformation—NAT2—head and neck cancer	0.000481	0.00167	CbGpPWpGaD
Flunitrazepam—CYP2A6—Biological oxidations—CYP1A1—head and neck cancer	0.00048	0.00167	CbGpPWpGaD
Flunitrazepam—CYP2C19—Arachidonic acid metabolism—PTGS2—head and neck cancer	0.000468	0.00163	CbGpPWpGaD
Flunitrazepam—CYP1A2—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.00043	0.00149	CbGpPWpGaD
Flunitrazepam—CYP2C9—Arachidonic acid metabolism—PTGS2—head and neck cancer	0.000427	0.00148	CbGpPWpGaD
Flunitrazepam—CYP2A6—Metabolism—UROD—head and neck cancer	0.000423	0.00147	CbGpPWpGaD
Flunitrazepam—CYP1A2—Phase II conjugation—GSTM1—head and neck cancer	0.000412	0.00143	CbGpPWpGaD
Flunitrazepam—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.000409	0.00142	CbGpPWpGaD
Flunitrazepam—CYP2B6—Biological oxidations—GSTM1—head and neck cancer	0.000409	0.00142	CbGpPWpGaD
Flunitrazepam—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.000404	0.0014	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metapathway biotransformation—GSTM1—head and neck cancer	0.000403	0.0014	CbGpPWpGaD
Flunitrazepam—CYP2E1—Biological oxidations—GSTM1—head and neck cancer	0.000401	0.00139	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metapathway biotransformation—GSTM1—head and neck cancer	0.000395	0.00137	CbGpPWpGaD
Flunitrazepam—GABRA6—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—head and neck cancer	0.000393	0.00136	CbGpPWpGaD
Flunitrazepam—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—head and neck cancer	0.00039	0.00136	CbGpPWpGaD
Flunitrazepam—CYP2B6—Biological oxidations—CYP1A1—head and neck cancer	0.000388	0.00135	CbGpPWpGaD
Flunitrazepam—GABRA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—head and neck cancer	0.000388	0.00135	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metapathway biotransformation—CYP1A1—head and neck cancer	0.000382	0.00133	CbGpPWpGaD
Flunitrazepam—CYP2E1—Biological oxidations—CYP1A1—head and neck cancer	0.00038	0.00132	CbGpPWpGaD
Flunitrazepam—CYP3A4—Biological oxidations—NAT2—head and neck cancer	0.000376	0.00131	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metapathway biotransformation—CYP1A1—head and neck cancer	0.000374	0.0013	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metapathway biotransformation—NAT2—head and neck cancer	0.000371	0.00129	CbGpPWpGaD
Flunitrazepam—CYP1A2—Arachidonic acid metabolism—PTGS2—head and neck cancer	0.000365	0.00127	CbGpPWpGaD
Flunitrazepam—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—head and neck cancer	0.000361	0.00126	CbGpPWpGaD
Flunitrazepam—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—head and neck cancer	0.000344	0.0012	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—UROD—head and neck cancer	0.000341	0.00119	CbGpPWpGaD
Flunitrazepam—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—head and neck cancer	0.000338	0.00118	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—UROD—head and neck cancer	0.000334	0.00116	CbGpPWpGaD
Flunitrazepam—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—head and neck cancer	0.000332	0.00116	CbGpPWpGaD
Flunitrazepam—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.000332	0.00115	CbGpPWpGaD
Flunitrazepam—UGT1A3—Metabolism—NAT2—head and neck cancer	0.00033	0.00115	CbGpPWpGaD
Flunitrazepam—GABRA6—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—head and neck cancer	0.000315	0.0011	CbGpPWpGaD
Flunitrazepam—GABRA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—head and neck cancer	0.000311	0.00108	CbGpPWpGaD
Flunitrazepam—CYP2C19—Biological oxidations—GSTM1—head and neck cancer	0.000309	0.00107	CbGpPWpGaD
Flunitrazepam—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—head and neck cancer	0.000307	0.00107	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metapathway biotransformation—GSTM1—head and neck cancer	0.000305	0.00106	CbGpPWpGaD
Flunitrazepam—GABRA6—Transmission across Chemical Synapses—MAPK1—head and neck cancer	0.000295	0.00103	CbGpPWpGaD
Flunitrazepam—CYP2C19—Biological oxidations—CYP1A1—head and neck cancer	0.000293	0.00102	CbGpPWpGaD
Flunitrazepam—GABRA4—Transmission across Chemical Synapses—MAPK1—head and neck cancer	0.000291	0.00101	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metapathway biotransformation—CYP1A1—head and neck cancer	0.000289	0.001	CbGpPWpGaD
Flunitrazepam—UGT1A3—Metabolism—DPYD—head and neck cancer	0.000289	0.001	CbGpPWpGaD
Flunitrazepam—GABRA1—SIDS Susceptibility Pathways—VEGFA—head and neck cancer	0.000289	0.001	CbGpPWpGaD
Flunitrazepam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—head and neck cancer	0.000283	0.000985	CbGpPWpGaD
Flunitrazepam—CYP2C9—Biological oxidations—GSTM1—head and neck cancer	0.000282	0.000979	CbGpPWpGaD
Flunitrazepam—UGT2B7—Metabolism—NAT2—head and neck cancer	0.00028	0.000974	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metapathway biotransformation—GSTM1—head and neck cancer	0.000278	0.000966	CbGpPWpGaD
Flunitrazepam—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—head and neck cancer	0.000276	0.000961	CbGpPWpGaD
Flunitrazepam—CYP1A2—Aryl Hydrocarbon Receptor—MAPK1—head and neck cancer	0.000276	0.000961	CbGpPWpGaD
Flunitrazepam—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—head and neck cancer	0.000276	0.000961	CbGpPWpGaD
Flunitrazepam—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—head and neck cancer	0.000276	0.000961	CbGpPWpGaD
Flunitrazepam—UGT1A3—Metabolism—YAP1—head and neck cancer	0.000274	0.000953	CbGpPWpGaD
Flunitrazepam—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—head and neck cancer	0.000272	0.000944	CbGpPWpGaD
Flunitrazepam—CYP2C9—Biological oxidations—CYP1A1—head and neck cancer	0.000267	0.000928	CbGpPWpGaD
Flunitrazepam—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—head and neck cancer	0.000267	0.000927	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metapathway biotransformation—CYP1A1—head and neck cancer	0.000263	0.000916	CbGpPWpGaD
Flunitrazepam—GABRA5—Transmission across Chemical Synapses—MAPK1—head and neck cancer	0.000259	0.0009	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—UROD—head and neck cancer	0.000258	0.000896	CbGpPWpGaD
Flunitrazepam—GABRA3—Transmission across Chemical Synapses—MAPK1—head and neck cancer	0.000254	0.000884	CbGpPWpGaD
Flunitrazepam—GABRA2—Transmission across Chemical Synapses—MAPK1—head and neck cancer	0.00025	0.000868	CbGpPWpGaD
Flunitrazepam—UGT2B7—Metabolism—DPYD—head and neck cancer	0.000246	0.000854	CbGpPWpGaD
Flunitrazepam—CYP1A2—Biological oxidations—GSTM1—head and neck cancer	0.000241	0.000837	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metapathway biotransformation—GSTM1—head and neck cancer	0.000237	0.000825	CbGpPWpGaD
Flunitrazepam—GABRA6—Transmission across Chemical Synapses—HRAS—head and neck cancer	0.000237	0.000823	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—UROD—head and neck cancer	0.000235	0.000817	CbGpPWpGaD
Flunitrazepam—GABRA4—Transmission across Chemical Synapses—HRAS—head and neck cancer	0.000234	0.000813	CbGpPWpGaD
Flunitrazepam—UGT2B7—Metabolism—YAP1—head and neck cancer	0.000233	0.00081	CbGpPWpGaD
Flunitrazepam—CYP1A2—Biological oxidations—CYP1A1—head and neck cancer	0.000228	0.000793	CbGpPWpGaD
Flunitrazepam—UGT1A1—Metabolism—NAT2—head and neck cancer	0.000228	0.000791	CbGpPWpGaD
Flunitrazepam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—head and neck cancer	0.000228	0.000791	CbGpPWpGaD
Flunitrazepam—GABRA6—Neuronal System—MAPK1—head and neck cancer	0.000226	0.000786	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metapathway biotransformation—CYP1A1—head and neck cancer	0.000225	0.000782	CbGpPWpGaD
Flunitrazepam—GABRA4—Neuronal System—MAPK1—head and neck cancer	0.000223	0.000776	CbGpPWpGaD
Flunitrazepam—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—head and neck cancer	0.000222	0.000771	CbGpPWpGaD
Flunitrazepam—GABRA1—Transmission across Chemical Synapses—MAPK1—head and neck cancer	0.000213	0.00074	CbGpPWpGaD
Flunitrazepam—GABRA5—Transmission across Chemical Synapses—HRAS—head and neck cancer	0.000208	0.000722	CbGpPWpGaD
Flunitrazepam—GABRA3—Transmission across Chemical Synapses—HRAS—head and neck cancer	0.000204	0.000709	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—UROD—head and neck cancer	0.000201	0.000698	CbGpPWpGaD
Flunitrazepam—GABRA2—Transmission across Chemical Synapses—HRAS—head and neck cancer	0.000201	0.000697	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	0.0002	0.000695	CbGpPWpGaD
Flunitrazepam—UGT1A1—Metabolism—DPYD—head and neck cancer	0.0002	0.000694	CbGpPWpGaD
Flunitrazepam—GABRA5—Neuronal System—MAPK1—head and neck cancer	0.000198	0.000689	CbGpPWpGaD
Flunitrazepam—GABRA3—Neuronal System—MAPK1—head and neck cancer	0.000195	0.000677	CbGpPWpGaD
Flunitrazepam—GABRA2—Neuronal System—MAPK1—head and neck cancer	0.000191	0.000665	CbGpPWpGaD
Flunitrazepam—UGT1A1—Metabolism—YAP1—head and neck cancer	0.000189	0.000658	CbGpPWpGaD
Flunitrazepam—CYP3A4—Biological oxidations—GSTM1—head and neck cancer	0.000186	0.000646	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metapathway biotransformation—GSTM1—head and neck cancer	0.000183	0.000637	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	0.000182	0.000634	CbGpPWpGaD
Flunitrazepam—GABRA6—Neuronal System—HRAS—head and neck cancer	0.000182	0.000631	CbGpPWpGaD
Flunitrazepam—GABRA4—Neuronal System—HRAS—head and neck cancer	0.000179	0.000623	CbGpPWpGaD
Flunitrazepam—CYP3A4—Biological oxidations—CYP1A1—head and neck cancer	0.000176	0.000612	CbGpPWpGaD
Flunitrazepam—CYP2A6—Metabolism—NAT2—head and neck cancer	0.000176	0.00061	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metapathway biotransformation—CYP1A1—head and neck cancer	0.000174	0.000604	CbGpPWpGaD
Flunitrazepam—GABRA1—Transmission across Chemical Synapses—HRAS—head and neck cancer	0.000171	0.000594	CbGpPWpGaD
Flunitrazepam—UGT1A3—Metabolism—TYMS—head and neck cancer	0.000165	0.000572	CbGpPWpGaD
Flunitrazepam—GABRA1—Neuronal System—MAPK1—head and neck cancer	0.000163	0.000567	CbGpPWpGaD
Flunitrazepam—UGT1A3—Metabolism—GSTM1—head and neck cancer	0.000163	0.000566	CbGpPWpGaD
Flunitrazepam—GABRA5—Neuronal System—HRAS—head and neck cancer	0.000159	0.000554	CbGpPWpGaD
Flunitrazepam—GABRA3—Neuronal System—HRAS—head and neck cancer	0.000156	0.000544	CbGpPWpGaD
Flunitrazepam—UGT1A3—Metabolism—GPX1—head and neck cancer	0.000156	0.000542	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	0.000156	0.000541	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—UROD—head and neck cancer	0.000155	0.000539	CbGpPWpGaD
Flunitrazepam—UGT1A3—Metabolism—CYP1A1—head and neck cancer	0.000154	0.000536	CbGpPWpGaD
Flunitrazepam—CYP2A6—Metabolism—DPYD—head and neck cancer	0.000154	0.000535	CbGpPWpGaD
Flunitrazepam—GABRA2—Neuronal System—HRAS—head and neck cancer	0.000154	0.000534	CbGpPWpGaD
Flunitrazepam—CYP2A6—Metabolism—YAP1—head and neck cancer	0.000146	0.000508	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—NAT2—head and neck cancer	0.000142	0.000492	CbGpPWpGaD
Flunitrazepam—UGT2B7—Metabolism—TYMS—head and neck cancer	0.00014	0.000487	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—NAT2—head and neck cancer	0.000139	0.000482	CbGpPWpGaD
Flunitrazepam—UGT2B7—Metabolism—GSTM1—head and neck cancer	0.000138	0.000481	CbGpPWpGaD
Flunitrazepam—UGT2B7—Metabolism—GPX1—head and neck cancer	0.000133	0.000461	CbGpPWpGaD
Flunitrazepam—UGT2B7—Metabolism—CYP1A1—head and neck cancer	0.000131	0.000456	CbGpPWpGaD
Flunitrazepam—GABRA1—Neuronal System—HRAS—head and neck cancer	0.000131	0.000455	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—DPYD—head and neck cancer	0.000124	0.000432	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—DPYD—head and neck cancer	0.000122	0.000423	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—YAP1—head and neck cancer	0.000118	0.00041	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—YAP1—head and neck cancer	0.000115	0.000401	CbGpPWpGaD
Flunitrazepam—UGT1A1—Metabolism—TYMS—head and neck cancer	0.000114	0.000395	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	0.000114	0.000395	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	0.000112	0.000391	CbGpPWpGaD
Flunitrazepam—UGT1A1—Metabolism—GSTM1—head and neck cancer	0.000112	0.000391	CbGpPWpGaD
Flunitrazepam—UGT1A1—Metabolism—GPX1—head and neck cancer	0.000108	0.000374	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—NAT2—head and neck cancer	0.000107	0.000372	CbGpPWpGaD
Flunitrazepam—UGT1A1—Metabolism—CYP1A1—head and neck cancer	0.000107	0.00037	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	0.000104	0.00036	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	0.000103	0.000357	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—NAT2—head and neck cancer	9.76e-05	0.000339	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—DPYD—head and neck cancer	9.38e-05	0.000326	CbGpPWpGaD
Flunitrazepam—UGT1A3—Metabolism—PTGS2—head and neck cancer	9.17e-05	0.000319	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—YAP1—head and neck cancer	8.9e-05	0.000309	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	8.85e-05	0.000308	CbGpPWpGaD
Flunitrazepam—CYP2A6—Metabolism—TYMS—head and neck cancer	8.77e-05	0.000305	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	8.77e-05	0.000305	CbGpPWpGaD
Flunitrazepam—CYP2A6—Metabolism—GSTM1—head and neck cancer	8.67e-05	0.000301	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—DPYD—head and neck cancer	8.56e-05	0.000297	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—NAT2—head and neck cancer	8.34e-05	0.00029	CbGpPWpGaD
Flunitrazepam—CYP2A6—Metabolism—GPX1—head and neck cancer	8.3e-05	0.000288	CbGpPWpGaD
Flunitrazepam—CYP2A6—Metabolism—CYP1A1—head and neck cancer	8.22e-05	0.000286	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—YAP1—head and neck cancer	8.12e-05	0.000282	CbGpPWpGaD
Flunitrazepam—UGT1A3—Metabolism—PTEN—head and neck cancer	8e-05	0.000278	CbGpPWpGaD
Flunitrazepam—UGT2B7—Metabolism—PTGS2—head and neck cancer	7.8e-05	0.000271	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—DPYD—head and neck cancer	7.31e-05	0.000254	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—TYMS—head and neck cancer	7.08e-05	0.000246	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—GSTM1—head and neck cancer	6.99e-05	0.000243	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—YAP1—head and neck cancer	6.94e-05	0.000241	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—TYMS—head and neck cancer	6.93e-05	0.000241	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—GSTM1—head and neck cancer	6.85e-05	0.000238	CbGpPWpGaD
Flunitrazepam—UGT2B7—Metabolism—PTEN—head and neck cancer	6.8e-05	0.000236	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—GPX1—head and neck cancer	6.7e-05	0.000233	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	6.69e-05	0.000233	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—CYP1A1—head and neck cancer	6.63e-05	0.00023	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—GPX1—head and neck cancer	6.56e-05	0.000228	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—CYP1A1—head and neck cancer	6.49e-05	0.000226	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—NAT2—head and neck cancer	6.43e-05	0.000224	CbGpPWpGaD
Flunitrazepam—UGT1A1—Metabolism—PTGS2—head and neck cancer	6.34e-05	0.00022	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	6.1e-05	0.000212	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	5.83e-05	0.000203	CbGpPWpGaD
Flunitrazepam—UGT1A3—Metabolism—PIK3CA—head and neck cancer	5.64e-05	0.000196	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—DPYD—head and neck cancer	5.64e-05	0.000196	CbGpPWpGaD
Flunitrazepam—UGT1A1—Metabolism—PTEN—head and neck cancer	5.53e-05	0.000192	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—YAP1—head and neck cancer	5.35e-05	0.000186	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—TYMS—head and neck cancer	5.35e-05	0.000186	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	5.32e-05	0.000185	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—GSTM1—head and neck cancer	5.28e-05	0.000184	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	5.21e-05	0.000181	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—GPX1—head and neck cancer	5.06e-05	0.000176	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—CYP1A1—head and neck cancer	5.01e-05	0.000174	CbGpPWpGaD
Flunitrazepam—CYP2A6—Metabolism—PTGS2—head and neck cancer	4.89e-05	0.00017	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—TYMS—head and neck cancer	4.87e-05	0.000169	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—GSTM1—head and neck cancer	4.82e-05	0.000167	CbGpPWpGaD
Flunitrazepam—UGT2B7—Metabolism—PIK3CA—head and neck cancer	4.8e-05	0.000167	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—GPX1—head and neck cancer	4.61e-05	0.00016	CbGpPWpGaD
Flunitrazepam—UGT1A3—Metabolism—AKT1—head and neck cancer	4.61e-05	0.00016	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—CYP1A1—head and neck cancer	4.57e-05	0.000159	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	4.55e-05	0.000158	CbGpPWpGaD
Flunitrazepam—CYP2A6—Metabolism—PTEN—head and neck cancer	4.26e-05	0.000148	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—TYMS—head and neck cancer	4.17e-05	0.000145	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—GSTM1—head and neck cancer	4.12e-05	0.000143	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	4.12e-05	0.000143	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—GPX1—head and neck cancer	3.94e-05	0.000137	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—PTGS2—head and neck cancer	3.94e-05	0.000137	CbGpPWpGaD
Flunitrazepam—UGT2B7—Metabolism—AKT1—head and neck cancer	3.92e-05	0.000136	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—CYP1A1—head and neck cancer	3.9e-05	0.000136	CbGpPWpGaD
Flunitrazepam—UGT1A1—Metabolism—PIK3CA—head and neck cancer	3.9e-05	0.000136	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—PTGS2—head and neck cancer	3.86e-05	0.000134	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	3.75e-05	0.00013	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—PTEN—head and neck cancer	3.44e-05	0.00012	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—PTEN—head and neck cancer	3.37e-05	0.000117	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—TYMS—head and neck cancer	3.22e-05	0.000112	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	3.21e-05	0.000111	CbGpPWpGaD
Flunitrazepam—UGT1A1—Metabolism—AKT1—head and neck cancer	3.19e-05	0.000111	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—GSTM1—head and neck cancer	3.18e-05	0.00011	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—GPX1—head and neck cancer	3.04e-05	0.000106	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—CYP1A1—head and neck cancer	3.01e-05	0.000105	CbGpPWpGaD
Flunitrazepam—CYP2A6—Metabolism—PIK3CA—head and neck cancer	3.01e-05	0.000104	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—PTGS2—head and neck cancer	2.98e-05	0.000104	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—PTGS2—head and neck cancer	2.72e-05	9.44e-05	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—PTEN—head and neck cancer	2.6e-05	9.03e-05	CbGpPWpGaD
Flunitrazepam—CYP2A6—Metabolism—AKT1—head and neck cancer	2.46e-05	8.54e-05	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—PIK3CA—head and neck cancer	2.43e-05	8.43e-05	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—PIK3CA—head and neck cancer	2.38e-05	8.26e-05	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—PTEN—head and neck cancer	2.37e-05	8.23e-05	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—PTGS2—head and neck cancer	2.32e-05	8.07e-05	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—PTEN—head and neck cancer	2.02e-05	7.04e-05	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—AKT1—head and neck cancer	1.98e-05	6.89e-05	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—AKT1—head and neck cancer	1.94e-05	6.75e-05	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—PIK3CA—head and neck cancer	1.83e-05	6.37e-05	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—PTGS2—head and neck cancer	1.79e-05	6.23e-05	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—PIK3CA—head and neck cancer	1.67e-05	5.81e-05	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—PTEN—head and neck cancer	1.56e-05	5.43e-05	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—AKT1—head and neck cancer	1.5e-05	5.2e-05	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—PIK3CA—head and neck cancer	1.43e-05	4.96e-05	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—AKT1—head and neck cancer	1.37e-05	4.75e-05	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—AKT1—head and neck cancer	1.17e-05	4.06e-05	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—PIK3CA—head and neck cancer	1.1e-05	3.83e-05	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—AKT1—head and neck cancer	9e-06	3.13e-05	CbGpPWpGaD
